Bonn, Germany – 22nd October 2012 – SAW Instruments, developer of the innovative sam® family of biosensors for real-time, label-free assays, has commissioned a survey to identify the current challenges affecting researchers at the forefront of molecular binding studies and kinetic analysis. By providing answers to 12 quick multiple-choice questions, respondents will be given access to some of the more interesting findings and will be entered into the draw to win a brand new Kindle Fire™. Topics under discussion include the biggest technical challenge in biosensing for life science applications, as well as the main current limitations with existing technologies. The survey comes at a pertinent time, as several models of well-known, older biosensor equipment are being discontinued and service support removed.
For your chance to win a Kindle Fire™ fill out the full survey* now, or visit www.saw-instruments.com to find out more about the latest innovations in biosensing technology.
* Amazon, Kindle, Kindle Fire, the Amazon Kindle logo and the Kindle Fire logo are trademarks of Amazon.com, Inc. or its affiliates. The Kindle device will be given away on behalf of SAW Instruments. Amazon EU Sarl is not a sponsor of this survey. This survey closes on November 30th 2012. Terms and conditions apply. You must complete all survey questions to be entered into the Kindle Fire™ draw.
Notes on the technology
Surface Acoustic Wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analysed. Thus, the nature of the surface in question, and therefore any changes to it, can be assessed by sensors monitoring the behaviour of the wave as it propagates across the surface. In particular, changes in mass result in alterations to the phase of the wave, whilst viscoelastic and conformational characteristics influence wave amplitude. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.
About SAW Instruments GmbH
SAW Instruments GmbH, headquartered in Bonn, Germany, designs, develops and sells biosensor-based laboratory instruments for life sciences research. The proprietary technology of SAW Instruments employs a Surface Acoustic Waves approach to biological measurement, rather than using traditional optical methods such as SPR. The technology is used to measure protein binding kinetics and affinity constants.
SAW instruments has more than ten years experience in the field of label-free biosensor technology and a number of our customers have successfully published work employing the platform. It is our goal is to continue to build on this experience, as well as to develop a family of workflow-driven products to further meet our customers’ needs.
About SAW Instruments USA, LLC
SAW Instruments USA, LLC is a wholly owned US subsidiary of SAW Instruments GmbH.